Glaxo boosted by US patent ruling on anti-depressant drug

Glaxosmithkline raised hopes it could head off potential rivals to one of its top-selling drugs yesterday and reassured investors by repeating its earnings guidance.

Europe's biggest drug maker said a US judge had ruled in its favour on one patent related to its anti-depressant drug Paxil, but had also decided in favour of the private Canadian company Apotex on another.

The company said the judge for the Eastern District of Pennsylvania had split the decision on the remaining two disputed patents, holding some claims in the patents invalid and denying Apotex's motions on others.

GSK, which is battling against cheap generic versions of its blockbuster drugs, said it would seek an appeal against the ruling that one patent was invalid. The dispute over the remaining three patents will go forward to a court case.

"Glaxo continues to believe there are significant hurdles that prevent launch of a generic Paxil product," the company said. "Accordingly, Glaxo's published earnings guidance for 2002 and 2003 remains as previously stated."

The company expects to deliver growth in earnings per share of at least 10 per cent in 2002 and high single-digits in 2003, assuming it successfully defends its Paxil patents.

Steve Plag, pharmaceuticals analyst at Credit Suisse First Boston, said: "This is clearly very good news as it means the second patent case now goes to trial in one of the slowest courts in the US, which should mean no resolution to the Paxil case until the end of 2003 at the earliest."

The shares rose 27p to 1,147p.

Paxil, which belongs to the same class of anti-depressants as Prozac, sold by Eli Lilly, has been a huge commercial success for GSK, generating global sales of £1.86bn last year.

Another analyst said the news was mildly positive for GSK. "If they had lost all four patents, Apotex would probably have just launched their product.... This was potentially very negative and that's been removed now for another six months," the analyst said.

Glaxo is also pursuing another case against Apotex in Chicago over its patent covering the hemihydrate form of Paxil, which expires in 2006.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
ebooks
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Software Development Manager

£40000 - £50000 per annum: Recruitment Genius: This is an exciting opportunity...

Ashdown Group: Product Manager - (Product Marketing, Financial Services)

£30000 - £35000 per annum + Benefits: Ashdown Group: Marketing Manager - Marke...

Recruitment Genius: Compliance Assistant

£13000 per annum: Recruitment Genius: This Pension Specialist was established ...

Ashdown Group: Market Research Executive

£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...

Day In a Page

Isis hostage crisis: The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power

Isis hostage crisis

The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power, says Robert Fisk
Missing salvage expert who found $50m of sunken treasure before disappearing, tracked down at last

The runaway buccaneers and the ship full of gold

Salvage expert Tommy Thompson found sunken treasure worth millions. Then he vanished... until now
Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

Maverick artist Grayson Perry backs our campaign
Assisted Dying Bill: I want to be able to decide about my own death - I want to have control of my life

Assisted Dying Bill: 'I want control of my life'

This week the Assisted Dying Bill is debated in the Lords. Virginia Ironside, who has already made plans for her own self-deliverance, argues that it's time we allowed people a humane, compassionate death
Move over, kale - cabbage is the new rising star

Cabbage is king again

Sophie Morris banishes thoughts of soggy school dinners and turns over a new leaf
11 best winter skin treats

Give your moisturiser a helping hand: 11 best winter skin treats

Get an extra boost of nourishment from one of these hard-working products
Paul Scholes column: The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him

Paul Scholes column

The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him
Frank Warren column: No cigar, but pots of money: here come the Cubans

Frank Warren's Ringside

No cigar, but pots of money: here come the Cubans
Isis hostage crisis: Militant group stands strong as its numerous enemies fail to find a common plan to defeat it

Isis stands strong as its numerous enemies fail to find a common plan to defeat it

The jihadis are being squeezed militarily and economically, but there is no sign of an implosion, says Patrick Cockburn
Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action

Virtual reality: Seeing is believing

Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action
Homeless Veterans appeal: MP says Coalition ‘not doing enough’

Homeless Veterans appeal

MP says Coalition ‘not doing enough’ to help
Larry David, Steve Coogan and other comedians share stories of depression in new documentary

Comedians share stories of depression

The director of the new documentary, Kevin Pollak, tells Jessica Barrett how he got them to talk
Has The Archers lost the plot with it's spicy storylines?

Has The Archers lost the plot?

A growing number of listeners are voicing their discontent over the rural soap's spicy storylines; so loudly that even the BBC's director-general seems worried, says Simon Kelner
English Heritage adds 14 post-war office buildings to its protected lists

14 office buildings added to protected lists

Christopher Beanland explores the underrated appeal of these palaces of pen-pushing
Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Scientists unearthed the cranial fragments from Manot Cave in West Galilee